Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A nemaline myopathy mutation in α-tropomyosin causes defective regulation of striated muscle force production
Daniel E. Michele, Faris P. Albayya, Joseph M. Metzger
Daniel E. Michele, Faris P. Albayya, Joseph M. Metzger
View: Text | PDF
Article

A nemaline myopathy mutation in α-tropomyosin causes defective regulation of striated muscle force production

  • Text
  • PDF
Abstract

Nemaline myopathy (NM) is a rare autosomal dominant skeletal muscle myopathy characterized by severe muscle weakness and the subsequent appearance of nemaline rods within the muscle fibers. Recently, a missense mutation inTPM3, which encodes the slow skeletal α-tropomyosin (αTm), was linked to NM in a large kindred with an autosomal-dominant, childhood-onset form of the disease. We used adenoviral gene transfer to fully differentiated rat adult myocytes in vitro to determine the effects of NM mutant human αTm expression on striated muscle sarcomeric structure and contractile function. The mutant αTm was expressed and incorporated correctly into sarcomeres of adult muscle cells. The primary defect caused by expression of the mutant αTm was a decrease in the sensitivity of contraction to activating Ca2+, which could help explain the hypotonia seen in NM. Interestingly, NM mutant αTm expression did not directly result in nemaline rod formation, which suggests that rod formation is secondary to contractile dysfunction and that load-dependent processes are likely involved in nemaline rod formation in vivo.

Authors

Daniel E. Michele, Faris P. Albayya, Joseph M. Metzger

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
(a) Expression of thin filament proteins in adult myocytes expressing no...
(a) Expression of thin filament proteins in adult myocytes expressing normal and NM mutant αTm at days 5–6 after gene transfer. Two different viral titers (300 and 150 moi, respectively) for AdαTmFLAG M9R giving similar levels of expression were used in functional studies shown in Figure 4. Antibodies used in the panels from top to bottom were: Tm311 for Tm, 5C5 for sarcomeric actin, MAB1691 for troponin I, JLT-12 for troponin T. Soleus and superficial vastus lateralis were included to show migration of alternate myofilament protein isoforms. (b) Anti-FLAG immunofluorescence localization of the expressed epitope-tagged normal Tm (αTmFLAG) in a representative adult myocyte 5 days after gene transfer. (c) Anti-FLAG immunofluorescence localization of the expressed epitope-tagged NM mutant Tm (αTmFLAG M9R) in a representative adult myocyte 5 days after gene transfer. Insets in b and c show enlarged views of the striated anti-FLAG immunofluorescence staining in adult myocytes with arrowheads delineating the edges of the sarcomere (at each Z-line). Resting sarcomere length, ∼1.8–1.9 μm. At this sarcomere length, the thin filaments are overlapping, so segregated I-bands are not expected to be seen. Scale bars are 20 μm for the panels and 4 μm for the insets in b and c.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts